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Abstract 
Aim: The aims of this review are to explore and 
quantify the importance of blood glucose monitoring on 
glycaemic control in children and adolescents with Type 1 
Diabetes Mellitus (T1DM). 
Methods: A literature search of the major bibliographic 
databases found 11 observational studies which met the 
inclusion criteria of this review. 
Results: 9 of the 11 papers found a significant link 
between self-monitoring of blood glucose (SMBG) 
frequency and HbA1c reduction, with SMBG monitoring 4 
times daily leading to a further reduction in HbA1c of 1% 
compared to once daily monitoring. Frequent SMBG was 
correlated to higher social status, higher self-efficacy and 
increased parental involvement and was a sign of better 
global self-care behaviour. It was also noted that frequent 
SMBG leads to improved glycaemic control only if 
patients are taught what to do with the results and if they 
have an insulin regimen that allows for adjustment of 
insulin doses in response to blood glucose values. 
Conclusion: Frequent SMBG monitoring is an 
important part of diabetes self-management in children and 
adolescents with T1DM  because it results in a significant 
reduction in HbA1c. In the long-term this will lead to a 
reduction in the late complications of T1DM. Providing 
children and adolescents with T1DM in Malta with an 
adequate supply of glucose test strips should serve as an 
incentive for them to check their blood glucose regularly.  
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Introduction 
The Diabetes Control and Complications Trial in 
1994 had shown that an entire programme of intensive 
diabetes management with multiple daily injections of 
insulin or continuous subcutaneous insulin infusion by 
pumps, together with frequent self-monitoring of 
blood glucose (SMBG), significantly reduces and 
delays the micro- and macro-vascular complications of  
T1DM in adolescents and may also play a role in 
preserving residual beta cell function.
1-3
 However, it 
did not assess the effectiveness of SMBG on 
glycaemic control in its own right. 
This review looks at the advantages of SMBG, and 
discusses the evidence for the correlation between the 
frequency of SMBG and decrease in HbA1c in 
children and adolescents with T1DM. The results of a 
systematic search for studies which have looked at the 
frequency of SMBG and its impact on health outcomes 
in children and adolescents with T1DM are presented 
and results discussed. 
 
Aim 
The aims of this study are to explore and quantify 
the importance of blood glucose monitoring on 
glycaemic control in children and adolescents with 
Type 1 Diabetes Mellitus (T1DM). 
 
Background 
Intermittent self-monitoring of blood glucose 
SMBG is recommended in all current clinical 
guidelines of management of T1DM in children and 
adolescents.
4,5
 SMBG makes intensive diabetes 
management of glycaemia possible by assisting 
patients and health care providers evaluate therapeutic 
effectiveness, adjust insulin doses to correct out-of-
target glucose values and detect or prevent 
hypoglycaemia. All patients on an intensive multiple 
daily injection insulin regimen or on insulin pump 
therapy should monitor at least 3-4 times daily. Whilst 
periodic HbA1c testing indicates the mean blood 
glucose value over the preceding 2 to 3 months, 
SMBG provides immediate real-time feedback to 
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patients regarding glucose levels at various intervals 
throughout the day. Both tests are essential for assessing 
glycaemic control.  
The best way in which to systematically interpret 
SMBG data to optimise glucose control is by pattern 
management.
6
 A pattern of high readings at the same 
testing time each day, lasting at least three days in a row, 
or a pattern of low readings lasting two days in a row 
requires further examination to determine the source of the 
problem and insulin dose adjustment to improve control. 
Patients can document SMBG readings either by using a 
written logbook in which daily readings are entered in a 
single row so that the readings at the same time each day 
line up in a column, together with notes on insulin doses, 
exercise, food consumption and hypoglycaemic episodes. 
Meter data can also be downloaded on to a computer in the 
clinic, patients’ homes or on the internet and it is important 
that the time and date are properly entered into the meter 
to ensure accurate downloads. The latter two options will 
allow more time for data interpretation during clinic visits. 
Computerised data management allows for a better 
assessment of relationships between blood glucose, insulin, 
meals and activity. Most meter software programmes can 
provide pie-charts, bar-graphs and electronic logbooks 
which show the average frequency of meter readings, their 
mean value over a certain number of days and during set 
time periods within each day, as well as the percentage of 
readings above, below and within target ranges. Standard 
deviation (SD) values are also provided. An SD less than 
half of the mean blood glucose indicates severe insulin 
deficiency either because of missed insulin doses, poor 
matching of carbohydrate intake and insulin, missed meals 
or erratic insulin absorption secondary to lipohypertrophy.  
The glucose meters available today are capable of 
producing results that meet established standards of 
accuracy. However accuracy of SMBG data depends on 
proper use of meters by patients. Errors might arise due to 
insufficient cleansing of finger tips, inappropriate 
squeezing to obtain a drop of blood, failure to match 
calibration codes to strips and soiled meters. Glucose strips 
exposed to humidity, excess of temperature or high 
altitude may give falsely elevated results.  
 
Methods 
The main question addressed in this review was ‘Does 
self-monitoring of blood glucose levels lead to improved 
glycaemic control as measured by HbA1c in children and 
adolescents with T1DM.’  A literature search of major 
bibliographic databases including Ovid Medline (1950 to 
week 3, 2011) and EMBASE (1980 to week 14, 2011) was 
undertaken in April 2011. The inclusion criteria included 
children up to 18 years of age with T1DM. Study designs 
could be experimental and observational studies. Case 
reports were excluded. The intervention studied was 
SMBG and the outcome was impact on HbA1c. The search 
strategy combined the following key words: Type 1 
diabetes mellitus, self-monitoring of blood glucose, 
HbA1c and was limited to ‘all child 0-18 years’. The 
references of articles judged to be relevant were also 
manually searched for any additional studies. 
 
Results 
The initial search yielded 380 references. Analysis 
of the abstracts identified 13 articles which were 
deemed relevant to answer the question addressed in 
this review. Two were review articles on SMBG which 
focussed mainly on adults.
6,7
 The other 11 papers were 
observational studies. No randomised controlled trials 
were identified. Two of the 11 papers did not find a 
link between SMBG frequency and HbA1c.
8,9
 Table 1 
gives a summary of the 9 studies which found a 
positive correlation between SMBG and HbA1c. Of 
these, 7 were cross-sectional studies and 2 were long 
term observational studies. 
 
Discussion 
The correlation between frequency of SMBG and 
better HbA1c levels in children, as in adults,
7
 comes 
mainly from observational studies. Non-experimental 
studies may be of value in assessing the importance of 
SMBG in diabetes because there are ethical issues 
associated with conducting a randomised controlled 
trial in which a group of patients are denied an 
intervention which, despite a lack of high-quality 
supportive evidence, is a well-established part of 
routine clinical diabetes management. Observational 
studies also assess efficacy of SMBG under real-life 
conditions and most involve a large number of patients.  
Seven of the studies were cross-sectional and thus 
examined the association of blood glucose monitoring 
with HbA1c at one point in time
13-18 
or over a 
relatively short time-frame of two weeks.
10 
Two recent 
studies examined the association over a longer period 
of time.
11,12 
Anderson et al
13
 and Levine B-S et al
14
 assessed the 
frequency of SMBG by self-report measures 
(questionnaires or from data on logbooks). Haller et 
al
10 
and Helgeson et al
11
 downloaded data from meters 
in the clinic or at home. The studies by Dorchy et al
15
, 
Moreland et al
16
 and Svensson et al
12
 used both data 
from meters and from logbooks. In the study by Evans 
et al
17
, SMBG was inferred from dispensing of glucose 
test strips whilst Ziegler et al
18 
extracted data from a 
database of diabetes care and outcome.  
When data is determined exclusively by self-report, 
a relation between SMBG frequency and HbA1c may 
be under-or over-estimated as patients can easily 
manufacture or distort the number of times they check 
blood glucose. In fact, the two studies
8,9 
in the 
literature which found no links between SMBG  
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Table 1: Non-experimental studies assessing the impact of SMBG in T1DM children/adolescents 
 
 
 
Reference 
Study design 
 
Setting Inclusion criteria 
including 
treatment 
Number of 
subjects 
Main measures Main Outcomes 
Anderson et 
al (1997) 
Cross-
sectional 
study 
U.S. Pediatric 
hospital clinic 
Preadolescents and 
adolescents with 
diabetes for > 1 year 
? insulin regimen 
51  
(10-12 yrs) 
38  
(13-15 yrs) 
1. HbA1c                                 
2. Assessment of 
adherence to SMBG 
based on blood 
glucose data at O/P 
visit                              
3. Parental 
involvement in 
SMBG 
1.↑ frequency of SMBG associated with lower 
HbA1c level 
SMBG ≤1/day: HbA1c 9.9±0.44% 
SMBG 2-3/day: HbA1c 8.7±0.17% 
SMBG ≥4/day: HbA1c 8.3±0.22% 
2.↑frequency of SMBG significant predictor of better 
glycaemic control. r²=0.19, p<0.02 
3. Parental involvement in SMBG significantly 
related to adherence to SMBG 
4. SMBG performed more often in younger than in 
older patients 
Evans et al 
(1999) 
Cross-
sectional 
study 
U.K. diabetes 
database 
Adults and children 
with T1DM 
? insulin regimen 
807 1. SMBG frequency 
inferred from 
number of strips 
dispensed. 
2. 1st HbA1c  
In 258 patients with one valid HbA1c the total 
number of strips dispensed was a significant 
predictor of HbA1c (p<0.001) with a decline in 
HbA1c of 0.7% for every 180 strips dispensed over 
the 6 month period prior to taking HbA1c i.e. 
equivalent to one extra test/day 
Levine et al 
(2001) 
Cross-
sectional 
study 
U.S. Pediatric 
Hospital clinic 
Children 7-16 yrs  
T1DM  >6months. 
One O/P visit 1.yr 
prior study. 
No medical or 
psychiatric problem. 
35%: 1-2 inj daily 
61%: 3 inj daily  
4%: ≥4 inj daily 
300 1. Frequency of 
SMBG determined 
by clinician’s notes 
in patients’ charts. 
2. HbA1c. 
Frequency of SMBG was a significant modifiable 
predictor of HbA1c r²=0.12, p<0.0001 
SMBG ≤1/day: HbA1c 9.1%±0.34%  SMBG  3/day : 
HbA1c 8.9%±0.16% SMBG ≥5/day: HbA1c 
8.0%±0.31% 
 
 
 
 
Dorchy et al 
(1997) 
Cross-
sectional 
study 
Belgian 
Outpatients clinic 
Children <18 years 
of age with T1DM 
for >5 months. 
89.5%:conventional 
11.6%:MDI 
144 1. HbA1c.                                     
2. Frequency of 
SMBG from data in 
log book and from 
meter. 
After 2 years of diabetes, HbA1c negatively 
correlated with frequency of SMBG 
Haller et al 
(2004) 
Cross-
sectional 
study 
Children/ 
adolescents 
attending a 
diabetes camp. 
9-15 yr children 
with T1DM  >1 yr. 
31%: MDI 
10%: pump 
59%: conventional 
229 Frequency of SMBG 
in parent records of  
meter data of 
children two weeks 
prior to camp. 
1.↑SMBG frequency correlated with lower HbA1c 
(r=0.15, p=0.006) 
2. HbA1c decreased by 0.4% for each additional 
SMBG/day 
Moreland et 
al (2004) 
Cross-
sectional 
study 
U.S. Pediatric 
Hospital Clinic 
8-16 year olds with 
T1DM for ≥6months 
153 1. HbA1c 
2. Frequency of 
SMBG from meters 
& data from 
logbook 
BGM frequency was an independent predictor of 
HbA1c (p=0.03) 
SMBG 1/day: HbA1c 9.1% 
SMBG 2-3/day: HbA1c 8.7% 
SMBG 4-5/day: HbA1c 8.2% 
SMBG 6+/day: HbA1c 7.5% 
Svensson et 
al (2009) 
>10 year 
observational 
Multicentre 
Danish registry for 
Childhood 
Diabetes 
T1DM ≤18 yrs age 
16.3%: MDI 
25.9%: 3 inj daily 
57.8%: <=2 inj daily 
2705 SMBG based on 
electronic or written  
data 
1. SMBG frequency increased over the 10 year 
period (p<0.001) 
2. HbA1c of -0.9% with SMBG ≥4 times/day 
Ziegler et al 
(2011) 
Cross-
sectional 
study 
German/Austrian 
DPV-Weiss 
database (a 
standardized 
prospective 
computer based 
documentation of 
care and outcomes) 
T1DM ≤18 years of 
age on database 
between 1995-2006 
from 233 centers. 
11.7%: pump 
69.5%: MDI 
18.8%: <3 inj/day 
26,723 Mean/median values 
of data from the 
most recent year of 
diabetes care were 
extracted from 
database for: 
1. SMBG Frequency  
2. HbA1c 
1.↑frequency significantly associated with lower 
HbA1c up to 5 SMBG/day; for pump therapy 
showed further improvement in HbA1c with >5 
SMBG/day 
2.HbA1c ↓-0.2% every added SMBG/day p<0.001  
3. This ↓HbA1c was most pronounced with CSII -
0.27% vs -0.24% with  MDI vs. -0.09% with 
conventional therapy (p<0.001) 
Helgeson et 
al (2011) 
5-yr study 
observational 
longitudinal 
examining 
relation x5 
occasions 
U.S. Pediatric 
Hospital Clinic 
Adolescents with 
T1DM 
72%: MDI 
26%: pump 
2%: 2 injections 
daily 
136 1. Frequency of 
SMBG assessed by 
data downloaded 
from meters in clinic 
or in 16% of cases 
from patient’s 
logbook. 
2. HbA1c 
1. ↑frequency of SMBG significantly correlated with 
better glycaemic control; r = -0.32; p<0.001 
(Similar results when monitoring based on 
logbook was excluded) 
2. SMBG 2/day: HbA1c 9.07% 
    SMBG >5/day: HbA1c 8.12% 
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frequency and HbA1c, used self-report measures to assess 
frequency of SMBG. In the 3 year observational study by 
Belmonte et al
9 
there were other reasons why an 
association between HbA1c and SMBG frequency was not 
found. Patients were instructed to check their capillary 
blood glucose only twice daily and they were on a 
conventional insulin regime of 1-2 injections of 
intermediate acting insulin together with short acting 
insulin. In the cross-sectional study by Urbach et al
8 
, even 
though an independent association between frequency of 
glucose monitoring and HbA1c was not shown, a 
significant association (p<0.001) between the marital 
status of the biological parents (an important predictor of 
HbA1c in this study) and the number of glucose checks 
performed each day was found. Only 30.4% of children 
who checked their capillary glucose two or fewer times per 
day had married parents, compared with 75.2% of those 
children who checked three or more times daily. This 
suggests that the marital status of the parents influences 
glucose control through better compliance with good 
diabetes self-care skills such as blood glucose monitoring. 
Even though one must be cautious in interpreting the 
association of SMBG frequency and HbA1c on cross-
sectional analysis, the results of all these studies, which 
included a large number of patients in a clinic setting, are 
consistent and support the view that SMBG is an essential 
tool in diabetes management. The frequency of SMBG 
was statistically significant in predicting glycaemic control 
in all of these studies. However it explains only a 
relatively small proportion of the variability in HbA1c as 
shown by the square of correlation coefficient r²=0.19 in 
Anderson et al
13 
and r²=0.12 in Levine B-S et al.
14
 There 
are other factors and good health behaviours that relate to 
metabolic control and act as confounding factors e.g. 
physical activity, education, diet, family structure, 
socioeconomic status. 
 Anderson et al
13 
and Helgeson et al
11
 have studied the 
characteristics of patients that might affect blood glucose 
monitoring. Increased frequency was significantly 
correlated to higher social status, higher self-efficacy and 
increased parental involvement whilst decreased frequency 
was correlated to low self-esteem, stressful life events, 
lower parental support and poor relationships with 
parents.
11,13
 Frequent SMBG was also a sign of better 
global self-care behaviour (r=0.60; p<0.001).
13 
The studies by Ziegler et al
18
 and Helgeson  et al
11
 have 
made it clear that successful utilisation of SMBG requires 
patient knowledge, motivation and self-care skills and an 
insulin regimen that allows for adjustment of insulin dose 
in response to blood glucose values. With a conventional 
twice-daily insulin regimen there was a limited benefit of 
increasing SMBG frequency whilst the most benefit was 
found in insulin pump patients who can adjust treatment 
with each blood glucose measurement. In practice, 
providing algorithms on how to adjust insulin 
according to blood glucose readings, can be helpful. 
 
Conclusion 
When assessing these studies blood glucose 
monitoring four times daily or more, compared to 
once-daily blood glucose monitoring, is associated 
with a further reduction in HbA1c of about 1%, in 
children and adolescents with T1DM on insulin. This 
decrease will significantly contribute to reduce the 
occurrence of late diabetic complications in this group 
of patients, who are at an increased risk of developing 
late diabetes complications as a result of an expected 
long duration of the condition. These studies have also 
highlighted the importance of patient education and 
empowerment. There is no glycaemic benefit if 
patients are not capable of interpreting the SMBG 
result and using it to positively modify diabetes self-
management. 
At present, Maltese children and adolescents with 
type 1 diabetes are entitled to receive 50 blood glucose 
test strips free of charge every 28 days from the 
Department of Health. This amount is equivalent to 
about 1.79 blood glucose self-testing opportunities per 
day. In actual fact, type 1 diabetic children need to 
perform a minimum of 4 blood glucose tests every day, 
and on even more occasions if they run into situations 
where their blood glucose may suddenly become 
significantly destabilized (e.g. hypoglycaemic 
episodes, concurrent illness, unusual physical activity). 
The overwhelming majority of Maltese children 
already test 4 times daily as a minimum and all of our 
patients are taught how to adjust insulin doses 
depending on blood glucose results so that persistently 
high or low blood glucose readings are not maintained 
until the next clinic visit. They are also advised to 
contact the local diabetes team if they don’t feel 
confident to make the necessary adjustments 
themselves. All patients are given algorithms on how 
to adjust short acting insulin doses depending on blood 
glucose results. However a significant number 
complain that although they accept regular blood 
glucose monitoring as necessary, it imposes a 
considerable financial burden on their families. For 
this reason, it would be ideal for the Department of 
Health to provide each type 1 diabetic with the 
minimum requisite of 4 test-strips per day. This would 
serve as a strong incentive for patients to continue 
checking their blood glucose regularly as required. 
Such a change in free glucose test-strip entitlement 
would increase the cost to the Department of Health 
from €0.57 per patient per day to €1.28 per patient per 
day, but the financial savings from a reduction in long-
term diabetes-related complications (including diabetic 
retinopathy, nephropathy and neuropathy) in terms of 
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provision of healthcare and social services would be 
incalculable. 
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